| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 01/05/2005 | EP0912196B9 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 01/05/2005 | EP0682517B1 Photodynamic treatment of synovium |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 12/30/2004 | US20040267335 Switched photodynamic therapy apparatus and method |
| 12/30/2004 | US20040266748 Photosensitizing carbamate derivatives |
| 12/30/2004 | US20040265393 Non-invasive intravascular thrombolysis using modified ultrasound techniques |
| 12/30/2004 | US20040265231 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 12/30/2004 | US20040264853 Light probe for ultraviolet light activated gene transduction |
| 12/30/2004 | US20040264644 System to generate therapeutic radiation |
| 12/29/2004 | WO2004112708A2 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 12/29/2004 | WO2004112590A2 Methods of enhancing radiation effects with metal nanoparticles |
| 12/29/2004 | WO2004064727A3 Method of cancer treatment using hdac inhibitors |
| 12/29/2004 | EP1490315A1 Controlling chemical reactions by spectral chemistry and spectral conditioning |
| 12/29/2004 | EP1490053A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 12/29/2004 | EP1289562B1 Novel preparation of hypericin bonded with poly-n-vinylamides |
| 12/29/2004 | EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 12/29/2004 | EP0994725B1 Thermodynamic adaptive phased array system for activating thermosensititve liposomes in targeted drug delivery |
| 12/29/2004 | CN1558760A Photodynamic porphyrin antimicrobial agents |
| 12/28/2004 | US6835393 Enhanced transport using membrane disruptive agents |
| 12/28/2004 | US6835202 Apparatus and method for high energy photodynamic therapy of acne vulgaris and seborrhea |
| 12/23/2004 | WO2004110438A1 Agent for photodynamic diagnosis and therapy of oncological diseases |
| 12/23/2004 | WO2004110255A2 Antineoplastic agents targeted via glut transporters |
| 12/23/2004 | WO2004110151A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 12/23/2004 | US20040259949 Aminolevulinulic acid/5-/ and derivatives for healing wounds with heat and photosensitizers for ulcers |
| 12/23/2004 | US20040259855 Methods and devices for epithelial protection during photodynamic therapy |
| 12/23/2004 | US20040259854 Methods and devices for epithelial protection during photodynamic therapy |
| 12/23/2004 | US20040259811 Anticancer agents; emission of electrons killing cancer cells |
| 12/23/2004 | US20040259810 Porphyrin derivatives for photodynamic therapy |
| 12/23/2004 | US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis |
| 12/23/2004 | US20040258761 Dissolving a biocompatible, biodegradable polymer in solution comprising sublimable substance and an oil phase; emulsification, pouring into surfactant solution to breaking; shrinkage, washing; enhancement during ultrasound; tumors |
| 12/23/2004 | US20040258760 Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production |
| 12/23/2004 | DE3790581B4 Verfahren zur selektiven Vernichtung von hypoxischen Tumorzellen Process for the selective destruction of hypoxic tumor cells |
| 12/23/2004 | CA2528359A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 12/22/2004 | EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 12/22/2004 | EP1487464A1 Increasing tumor oxygen content by administration of stressed cells |
| 12/22/2004 | EP1487412A1 Chemosensitizing with liposomes containing oligonucleotides |
| 12/21/2004 | US6833373 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 12/21/2004 | US6833108 Method and apparatus for inactivating contaminants in blood products |
| 12/16/2004 | WO2004108919A1 Biological compositions comprising yeast cells and methods for treatment of cancer |
| 12/16/2004 | WO2004032963A3 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 12/16/2004 | US20040254172 Method of treating nausea, vomiting, retching or any combination thereof |
| 12/16/2004 | US20040254171 Method of treating nausea, vomiting, retching or any combination thereof |
| 12/16/2004 | US20040253268 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253267 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253266 Biological compositions and methods for treatment of esophageal cancer |
| 12/16/2004 | US20040253265 Biological compositions and methods for treatment of bladder cancer |
| 12/16/2004 | US20040253264 Biological compositions and methods for treatment of brain cancer |
| 12/16/2004 | US20040253263 Metabolically activating a culture of yeast cells by electromagnetic radiation, each defined by one of five frequency ranges and a broad range of field strength; conditioning in plant extracts and the gastric juice of animals; oral administration |
| 12/16/2004 | US20040253262 Biological compositions and methods for treatment of lymphoma |
| 12/16/2004 | US20040253261 Biological compositions and methods for treatment of pancreatic cancer |
| 12/16/2004 | US20040253260 Biological compositions and methods for treatment of cervical cancer |
| 12/16/2004 | US20040253259 Biological compositions and methods for treatment of kidney cancer |
| 12/16/2004 | US20040253258 Biological compositions and methods for treatment of testicular cancer |
| 12/16/2004 | US20040253257 Biological compositions and methods for treatment of liver cancer |
| 12/16/2004 | US20040253256 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253255 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active |
| 12/16/2004 | US20040253254 oral compositions comprising activated and conditioned yeast cells; process includes culturing yeast cells in electromagnetic fields |
| 12/16/2004 | US20040253253 Biological compositions and methods for treatment of stomach cancer |
| 12/16/2004 | US20040253252 Biological compositions and methods for treatment of leukemia |
| 12/16/2004 | US20040253251 Biological compositions and methods for treatment of ovarian cancer |
| 12/16/2004 | US20040253182 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/15/2004 | EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications |
| 12/15/2004 | EP1485377A1 Pyranones useful as atm inhibitors |
| 12/15/2004 | EP1485131A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer |
| 12/14/2004 | CA2285056C Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| 12/09/2004 | WO2004037983A3 Caged ligands and uses thereof |
| 12/09/2004 | WO2003101486A3 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/09/2004 | US20040248873 Photoreactive compounds and compositions |
| 12/09/2004 | US20040248062 Material for differently modifying the optical properties of different cells |
| 12/09/2004 | US20040248061 Material for differently modifying the optical properties of different cells |
| 12/09/2004 | US20040248058 Material for differently modifying the optical properties of different cells |
| 12/09/2004 | US20040247527 Incorporating a targeting moiety, a photodynamic therapy moiety (especially a two photon absorber), and a medical imaging agent (such as a chromophore, contrast agent, etc.). |
| 12/09/2004 | DE10321654A1 Verfahren zum Abtöten von Mikroorganismen A method for killing microorganisms |
| 12/09/2004 | DE102004007406A1 Nanobioprocessor for treatment or diagnosis, e.g. of Alzheimer's disease, comprises quantum dots coated with specific binding material and capable of being activated from a remote energy source |
| 12/08/2004 | EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins |
| 12/08/2004 | EP1482974A2 Electroporation methods for introducing bioactive agents into cells |
| 12/08/2004 | CN1553958A Photochemical internalization for delivery of molecules into the cytosol |
| 12/07/2004 | US6828321 Compounds specifically radiosensitize hypoxic tumor cells |
| 12/07/2004 | US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect |
| 12/02/2004 | WO2004103274A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 12/02/2004 | WO2004060916A3 Peptide compound containing boron |
| 12/02/2004 | WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 12/02/2004 | WO2003011106A3 Internal image antibodies for optical imaging and therapy |
| 12/02/2004 | US20040241160 Vegfr-1 antibodies to treat breast cancer |
| 12/02/2004 | US20040241095 Complex containing cyanine dyes; supplying to target tumor cells |
| 12/02/2004 | US20040238781 Using genistein; preadministering before exposure to radiation; prevent tissue damage |
| 12/02/2004 | CA2525557A1 Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidene-2,6-dione |
| 12/01/2004 | EP1263761B1 Compounds for pdt |
| 12/01/2004 | CN1551872A Biologically active methylene blue derivatives |
| 11/30/2004 | US6825343 1,3-dipolar cycloadditions to polypyrrolic macrocycles |
| 11/25/2004 | WO2004101516A2 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 11/25/2004 | WO2004101003A1 Method for eliminating microorganisms |
| 11/25/2004 | WO2004089356A3 Targeted bone marrow protection agents |
| 11/25/2004 | WO2003090599A3 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
| 11/25/2004 | US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer |
| 11/25/2004 | US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 11/25/2004 | US20040234624 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 11/25/2004 | US20040234497 complexing hyaluronic acidand cell surface receptor overexpression on cancer cell surfaces |
| 11/25/2004 | US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 11/25/2004 | CA2525447A1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |